Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
Top Cited Papers
Open Access
- 25 October 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (11), 816-829
- https://doi.org/10.1093/eurheartj/ehs224
Abstract
Iron is a micronutrient essential for cellular energy and metabolism, necessary for maintaining body homoeostasis. Iron deficiency is an important co-morbidity in patients with heart failure (HF). A major factor in the pathogenesis of anaemia, it is also a separate condition with serious clinical consequences (e.g. impaired exercise capacity) and poor prognosis in HF patients. Experimental evidence suggests that iron therapy in iron-deficient animals may activate molecular pathways that can be cardio-protective. Clinical studies have demonstrated favourable effects of i.v. iron on the functional status, quality of life, and exercise capacity in HF patients. It is hypothesized that i.v. iron supplementation may become a novel therapy in HF patients with iron deficiency.Keywords
This publication has 135 references indexed in Scilit:
- An overview of sarcopenia: facts and numbers on prevalence and clinical impactJournal of Cachexia, Sarcopenia and Muscle, 2010
- Hepcidin in anemia of chronic heart failureAmerican Journal of Hematology, 2010
- Cachexia as a major underestimated and unmet medical need: facts and numbersJournal of Cachexia, Sarcopenia and Muscle, 2010
- The emerging role of iron dyshomeostasis in the mitochondrial decay of agingMechanisms of Ageing and Development, 2010
- Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examplesArchives of Toxicology, 2010
- Evaluation and Treatment of Iron Deficiency Anemia: A Gastroenterological PerspectiveDigestive Diseases and Sciences, 2010
- Maternal and child undernutrition: global and regional exposures and health consequencesThe Lancet, 2008
- Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure: Data From the CHARM Program and the Duke DatabankJournal of the American College of Cardiology, 2007
- Intravenous Iron Alone for the Treatment of Anemia in Patients With Chronic Heart FailureJournal of the American College of Cardiology, 2006
- A precious metal: Iron, an essential nutrient for all cellsGenes & Nutrition, 2006